|210.08||-1.62||-0.77%||Vol 18.00K||1Y Perf -6.29%|
|Apr 19th, 2021 12:21 DELAYED|
|- -%||- -|
|Target Price||240.50||Analyst Rating||Strong Buy 1.33|
|Potential %||14.55||Finscreener Ranking||★★★★ 53.95|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★ 55.63|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★+ 64.47|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||4.45B||Earnings Rating||Neutral|
|Price Range Ratio 52W %||59.92||Earnings Date||6th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||6th May 2021|
|Estimated EPS Next Report||1.32|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||77.31K|
|Avg. Monthly Volume||105.60K|
|Avg. Quarterly Volume||109.98K|
ICU Medical Inc. (NASDAQ: ICUI) stock closed at 211.7 per share at the end of the most recent trading day (a 1.65% change compared to the prior day closing price) with a volume of 124.26K shares and market capitalization of 4.45B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 8000 people. ICU Medical Inc. CEO is Vivek Jain.
The one-year performance of ICU Medical Inc. stock is -6.29%, while year-to-date (YTD) performance is -1.3%. ICUI stock has a five-year performance of 100.49%. Its 52-week range is between 170.57 and 236.51, which gives ICUI stock a 52-week price range ratio of 59.92%
ICU Medical Inc. currently has a PE ratio of 50.70, a price-to-book (PB) ratio of 2.88, a price-to-sale (PS) ratio of 4.62, a price to cashflow ratio of 19.80, a PEG ratio of 2.32, a ROA of 4.82%, a ROC of 5.76% and a ROE of 5.79%. The company’s profit margin is 7.52%, its EBITDA margin is 15.30%, and its revenue ttm is $942.40 Million , which makes it $44.47 revenue per share.
Of the last four earnings reports from ICU Medical Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.32 for the next earnings report. ICU Medical Inc.’s next earnings report date is 06th May 2021.
The consensus rating of Wall Street analysts for ICU Medical Inc. is Strong Buy (1.33), with a target price of $240.5, which is +14.55% compared to the current price. The earnings rating for ICU Medical Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
ICU Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
ICU Medical Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 13.83, ATR14 : 6.57, CCI20 : 204.79, Chaikin Money Flow : 0.02, MACD : -1.71, Money Flow Index : 55.26, ROC : 1.91, RSI : 47.96, STOCH (14,3) : 83.62, STOCH RSI : 1.00, UO : 50.06, Williams %R : -16.38), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of ICU Medical Inc. in the last 12-months were: Brian Bonnell (Sold 0 shares of value $0 ), Christian Voigtlander (Option Excercise at a value of $0), Daniel Woolson (Option Excercise at a value of $0), David C. Greenberg (Sold 0 shares of value $0 ), David F. Hoffmeister (Sold 0 shares of value $0 ), Donald Abbey (Sold 0 shares of value $0 ), Elisha W. Finney (Sold 0 shares of value $0 ), Elisha W. Finney (Sold 1 580 shares of value $300 200 ), George A. Lopez (Option Excercise at a value of $3 703 665), George A. Lopez (Sold 130 000 shares of value $25 950 660 ), Kevin J. McGrody (Sold 0 shares of value $0 ), Robert S. Swinney (Option Excercise at a value of $233 130), Robert S. Swinney (Sold 877 shares of value $169 091 ), Virginia Ruth Sanzone (Option Excercise at a value of $0), Vivek Jain (Option Excercise at a value of $7 436 935), Vivek Jain (Sold 141 500 shares of value $29 675 049 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
This could take some time, please wait.